Funds and ETFs Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:09 2024-05-15 am EDT After market 03:53:40 pm
165.8 EUR +4.77% Intraday chart for Merck KGaA 164.5 -0.80%

ETFs positioned on Merck KGaA

Name Weight AuM 1st Jan change Investor Rating
0.05% 7 M€ +0.11% -
0.05% 786 M€ -.--%
0.05% 23 M€ -.--% -
0.05% 284 M€ -.--%
0.05% 283 M€ +19.85%
0.05% 206 M€ -.--%
0.04% 1,166 M€ +0.26% -
0.04% 607 M€ +0.05% -
0.04% 391 M€ +9.18% -
0.04% 0 M€ 0.00% -
0.03% 34 M€ +8.23% -
0.03% 45 M€ 0.00% -
0.02% 306 M€ +6.45% -
0.02% 39 M€ +5.31% -
0.02% 105 M€ +4.05% -
0.02% 17 M€ +2.74% -
0.01% 34 M€ +4.18% -
0.01% 234 M€ +7.27% -
0.01% 54 M€ +1.07% -
0.01% 8 M€ +0.48% -
0.00% 146 M€ -1.96% -
0.00% 1 M€ 0.00% -
0.00% 29 M€ -2.00% -
0.00% 25 M€ 0.00% -
298.38% 7 M€ +10.27% -
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
158.3 EUR
Average target price
179.8 EUR
Spread / Average Target
+13.59%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. Funds and ETFs Merck KGaA
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW